Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | BCL6 | P41182 | 1/20 | 0.34 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6187065 | 0.96 | SMN1; SMN2 (0.38) | PDE2ASMN1; SMN2MAPK1HPGDALDH1A1 | |
| SCHEMBL978477 | 0.88 | KMT2A (0.36) | PDE2ASMN1; SMN2MAPK1HPGDALDH1A1 | |
| SCHEMBL6410703 | 0.86 | PDGFRB (0.36) | PDE2ASMN1; SMN2MAPK1CRHR1KMT2A | |
| SCHEMBL8805553 | 0.83 | ALDH1A1 (0.47) | PDE2ASMN1; SMN2MAPK1HPGDALDH1A1 | |
| SCHEMBL5593123 | 0.83 | PDE2A (0.37) | PDE2ABCL6KMT2ANPC1CYP1A2 | |
| SCHEMBL6186989 | 0.83 | CRHR1 (0.40) | PDE2ASMN1; SMN2MAPK1HPGDALDH1A1 | |
| SCHEMBL6186174 | 0.83 | PDGFRB (0.38) | PDE2ASMN1; SMN2MAPK1CRHR1KMT2A | |
| SCHEMBL5593507 | 0.82 | BCL6 (0.38) | PDE2ASMN1; SMN2BCL6CDK2GSK3B | |
| SCHEMBL4811909 | 0.81 | PDE2A (0.43) | PDE2ASMN1; SMN2HPGDALDH1A1KDM4E | |
| SCHEMBL13920303 | 0.81 | PDE2A (0.43) | PDE2ASMN1; SMN2HPGDALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7329663-B2 | Substituted-triazolopyrimidines as anticancer agents | WYETH (US) | 2008-02-12 | — | — | US | claimed |
| EP-1066291-B8 | FUNGICIDAL 6-(2-HALO-4-ALKOXYPHENYL)-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2005-09-14 | — | — | EP | claimed |
| EP-1574513-A1 | Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines | Wyeth (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1066291-B1 | FUNGICIDAL 6-(2-HALO-4-ALKOXYPHENYL)-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2005-07-13 | — | — | EP | claimed |
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | AMERICAN HOME PRODUCTS CORPORATION | 2002-06-06 | — | — | US | claimed |
| EP-1066291-A1 | FUNGICIDAL 6-(2-HALO-4-ALKOXYPHENYL)-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 2001-01-10 | — | — | EP | claimed |
| US-5981534-A | USE IN AGRICULTURE OR RELATED FIELDS FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI SUCH AS ALTEMARIA SOLANI, BOTRYTIS CINEREA | AMERICAN CYANAMID COMPANY (US) | 1999-11-09 | — | — | US | claimed |
| WO-1999048893-A1 | FUNGICIDAL 6-(2-HALO-4-ALKOXYPHENYL)-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 1999-09-30 | — | — | WO | claimed |
| US-7329663-B2 | Substituted-triazolopyrimidines as anticancer agents | WYETH (US) | 2008-02-12 | — | — | US | disclosed |
| EP-1574513-A1 | Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines | Wyeth (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1066291-B1 | FUNGICIDAL 6-(2-HALO-4-ALKOXYPHENYL)-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2005-07-13 | — | — | EP | disclosed |
| EP-1307200-A2 | SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS | Wyeth (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | AMERICAN HOME PRODUCTS CORPORATION | 2002-06-06 | — | — | US | disclosed |
| WO-2002002563-A2 | SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS | WYETH (US) | 2002-01-10 | — | — | WO | disclosed |
| US-6284762-B1 | AGRICULTURE | AMERICAN CYANAMID COMPANY | 2001-09-04 | — | — | US | disclosed |
| US-5981534-A | USE IN AGRICULTURE OR RELATED FIELDS FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI SUCH AS ALTEMARIA SOLANI, BOTRYTIS CINEREA | AMERICAN CYANAMID COMPANY (US) | 1999-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | TUBB3, TUBA1C, TUBB1 | PDE2A 3218/4885SMN1; SMN2 655/4885MAPK1 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.